Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
AGEN
$3.85
-4.70%
Analyze
1M
-2.5%
3M
-35.4%
1Y
-11.5%
Market Cap:
$122.68M
Agenus Inc
Healthcare |
Biotechnology
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.
Click "Analyze" to generate stock analysis
AGEN Price Trend and Signals
AGEN Option Volumes & Open Interests (aggregated)
AGEN Put Call Ratios and IV (aggregated)
AGEN Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-29
Somewhat Bearish
price_signal
Quarterly low detected.